Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
JNMA J Nepal Med Assoc ; 61(257): 39-42, 2023 Jan 01.
Article in English | MEDLINE | ID: mdl-37203922

ABSTRACT

Introduction: Coronavirus disease can affect the renal system in various forms ranging from mild proteinuria to acute kidney injury, some even needing renal replacement therapy. This study aimed to find out the prevalence of acute kidney injury in patients admitted with COVID-19 at a tertiary care centre. Methods: This descriptive cross-sectional study was done in patients admitted in COVID-19 ward in our hospital from July 2021 to June 2022. Ethical approval was obtained from the Institutional Review Committee (Reference number: 066-077/078). The serum creatinine level was used for the diagnosis of acute kidney injury. Convenience sampling method was used. Point estimate and 95% Confidence Interval were calculated. Results: Out of 80 patients with COVID-19, the prevalence of acute kidney injury was 25 (31.25%) (21.09-41.41, 95% Confidence Interval). Conclusions: The prevalence of acute kidney injury in COVID-19 patients was similar to other studies done in similar settings. Keywords: acute kidney injury; COVID-19; Nepal.


Subject(s)
Acute Kidney Injury , COVID-19 , Humans , Tertiary Care Centers , COVID-19/epidemiology , Cross-Sectional Studies , Hospitalization , Acute Kidney Injury/epidemiology
2.
JNMA J Nepal Med Assoc ; 61(259): 255-258, 2023 Mar 01.
Article in English | MEDLINE | ID: mdl-37203939

ABSTRACT

Introduction: Anti-hypertensive medications are prescribed for the management of high blood pressure which is the leading cause of mortality in chronic hemodialysis patients. The objective of our study was to find out the prevalence of anti-hypertensive medication use among chronic hemodialysis patients visiting the outpatient Department of Nephrology of a tertiary care centre. Methods: This was a descriptive cross-sectional study conducted among chronic hemodialysis patients visiting the Department of Nephrology of a tertiary care centre from 2 April 2022 to 30 September 2022. Ethical approval was taken from the Institutional Review Committee (Reference number: 062-078/079). A convenience sampling method was used. Point estimate and 95% Confidence Interval were calculated. Results: The prevalence of anti-hypertensive medications use was present in 102 (97.14%) (93.95-100, 95% Confidence Interval) patient undergoing hemodialysis. The three common drugs prescribed for hypertensive patients were amlodipine 79 (77.45%), torsemide 59 (57.84%), and prazosin 48 (47.05%). Conclusions: The prevalence of antihypertensive medication use among patients undergoing hemodialysis was higher than other similar studies done in similar settings. Keywords: anti-hypertensive drugs; hemodialysis; prevalence.


Subject(s)
Hypertension , Nephrology , Humans , Outpatients , Antihypertensive Agents/therapeutic use , Cross-Sectional Studies , Tertiary Care Centers , Hypertension/drug therapy , Hypertension/epidemiology , Renal Dialysis
SELECTION OF CITATIONS
SEARCH DETAIL
...